Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sovenor Patch for Moderate Non-Malignant Pain
NCT02519387Phase 4Completed
- Sponsor
- Mundipharma
- Start
- Jul 2013
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Norspan in osteoarthritis (OA), rheumatoid arthritis (RA), low back pain (LBP) and 2 more, sponsored by Mundipharma. Primary endpoint: Box Scale-11 Pain Score at 3 months. Started Jul 2013; status: completed.
02
Drugs
Norspan
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)low back pain (LBP)arthralgiamyalgia
Beyond the preview
Go deeper on NCT02519387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02519387.